Ultragenyx Pharmaceutical Inc.

CA · United States · Reporting entity ID 100000196876

Total reported 2019–2025

$73.2M

#128 of 2,960 reporting companies — 0.1% of all reported industry payments

$3.73M in general payments across 30,345 records, plus $69.4M in research funding across 8,657 records.

How it breaks down

General payments $3,729,718

Research funding $69,442,924

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.